Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandospirone for functional dyspepsia with mild-to-moderate anxiety
ChiCTR2000029857Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tandospirone in functional dyspepsia (FD) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Interleukin-6, Interleukin-1 beta and 4 more. Started May 2017; status: recruiting.
02
Drugs
tandospirone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2000029857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029857.